Expert Review Of Hematology

Journal Title：Expert Review Of Hematology

Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.

近年来，先进的分子研究技术已经改变了血液学。随着对血液病的了解不断加深，我们现在有机会研究和评估新的生物疗法、新药物和药物组合、新的治疗方案和包括干细胞移植在内的新方法。我们还可以期待蛋白质组学、分子遗传学和生物标志物研究能够促进新的诊断方法和适当疗法的识别。我们对血细胞和造血组织的形成和功能的认识将进一步提高，对于血液学家来说，采用这些新模式并制定综合策略来确定最佳的患者护理将是一个重大挑战。《血液学专家评论》（1747-4086）将这些进展放在背景中，并探讨它们将如何直接转化为临床实践。

Expert Review Of Hematology创刊于2008年，由Taylor and Francis Ltd.出版商出版，收稿方向涵盖HEMATOLOGY全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 较慢,6-12周 ，影响因子指数2.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。